Cindy Yu Cindy Yu

The Spectator Podcast: the Brexit party, drugs, and fake lesbians

As the two main parties reel from their local election performances today, are we at the beginning of a golden age for smaller parties? James Forsyth evaluates the chances of the Brexit party – Nigel Farage’s new electoral outfit – in this week’s cover piece. The conclusion isn’t pretty for the Conservative party: the Brexit party is slicker than Ukip ever was, and two out of five Tory councillors are considering voting for them in the upcoming European elections. The party has also managed to perform better than Change UK, who seemed to have peaked at their launch a few months ago, demonstrating – James argues – the sheer anger that is out there in the constituencies with the way Brexit is going. On the podcast, Katy Balls talks to James and Matthew Goodwin, an expert on polling and Ukip.

This week’s episode also features a fiery exchange between lawyer Chris Daw QC, who argues for the legalisation of drugs, and Peter Hitchens, who does not… Given the sheer amount of resources that go into policing drug laws, not to mention the costs to drug users of an illegal market (consuming substances with unclear chemical makeup, turning up to unsafe drug deals, having little information for safe consumption), Chris argues that drugs should be legalised – but regulated. It’s fair to say that Peter did not agree. A long term advocate of a war on drugs, Peter argues that drug usage was a choice, that better enforcement would eradicate the problems that Chris mentions, and that drugs are ultimately damaging to the user. It’s a feisty one, not for the fainthearted.

Unlock unlimited access, free for a month

then subscribe from as little as £1 a week after that
SUBSCRIBE

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.

Or

Unlock more articles

REGISTER

Comments

Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in